Publisher： Bentham Science Publishers
E-ISSN： 1875-5704|14|7|902-903
ISSN： 1567-2018
Source： Current Drug Delivery, Vol.14, Iss.7, 2017-10, pp. : 902-903
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adverse reactions to first-line antituberculosis drugs
Expert Opinion on Drug Safety, Vol. 5, Iss. 2, 2006-03 ,pp. :
Access to resources
Recommend
Abacavir/lamivudine-based regimens effective in first-line use
Inpharma, Vol. 1, Iss. 1356, 2002-01 ,pp. :
Tuberculostatic Drugs Targeting Infections of the Central Nervous System
Anti-Infective Agents, Vol. 10, Iss. 2, 2012-07 ,pp. :